Sigyn Therapeutics Inc (SIGY)

[PennyStockTrader2]

Company valuation after reverse merger would be as follows:

Outstanding count was lowered 150x due to reverse split 150:1 on 8/10/2020, so 95,772,408 / 150 = 638,482 shares.

The combined company will dilute 3:1, so the new count would be 638,482 * 4 = 2,553,930 shares. Enterprise value would be:

$1/share = $2,553,930

$2/share = $5,107,861

$3/share = $7,661,792

You determine what the potential of this company is for what they are attempting to do.

Not sure what is happening to the Gold Mines, probably being let go, nothing mentioned.